Correspondence 0001193125-23-141890 from Rallybio Corp (RLYB) (CIK 0001739410) (RLYB)
Rallybio Corp (RLYB) (CIK 0001739410)
Date: May 11, 2023 · CIK: 0001739410 · Accession: 0001193125-23-141890
AI Filing Summary & Sentiment
File numbers found in text: 333-271748
Show Raw Text
CORRESP 1 filename1.htm CORRESP RALLYBIO CORPORATION 234 Church Street, Suite 1020 New Haven, CT 06510 May 11, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: Rallybio Corporation Registration Statement on Form S-3 (File No. 333-271748) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Rallybio Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-271748) (the “Registration Statement”), so that it will be declared effective at 4:00 p.m. Eastern Time on May 12, 2023, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume, counsel to the Company, to orally modify or withdraw this request for acceleration. It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Zachary Blume of Ropes & Gray LLP, counsel to the Company, at (617) 951-7663. Very truly yours, RALLYBIO CORPORATION By: /s/ Michael Greco Michael Greco General Counsel